Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > XNPT > Summary

Xenoport, Inc.
(XNPT)

18.92USD   Down 0.20 (1.05%)   
At 2:30AM IST
 Xenoport, Inc. (NasdaqNM:XNPT) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 18.92USD
Trade Time:2:30AM IST
Change:Down 0.20 (1.05%) 
Prev Close:19.12
Open:19.29
Bid:18.85 x 100
Ask:21.61 x 1000
1y Target Est:31.31
Day's Range:18.81 - 19.36
52wk Range:13.36 - 27.37
Volume:201,690
Avg Vol (3m):324,492
Market Cap:574.03M
P/E (ttm):N/A
EPS (ttm):-2.43
Div & Yield:N/A (N/A%)
Add XNPT to Portfolio   Download Data

HEADLINES

 
•InPlay: XenoPort announces extension of the Horizant PDUFA date to February 11, 2010 - Briefing.com  - Wed 2:43AM
•XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010 - Business Wire  - Wed 2:43AM
•Glaxo savings plan may hit XenoPort partnership - AP  - Fri, Feb 5
•XenoPort Announces Horizant as Brand Name for XP13512 - Business Wire  - Thu, Feb 4
•Biotech Calendar: Key Dates for February - TheStreet.com  - Tue, Feb 2
•XENOPORT INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - EDGAR Online  - Tue, Jan 19
•XenoPort to Present at the 28th Annual J.P. Morgan Healthcare Conference - Business Wire  - Fri, Jan 8
•XENOPORT INC Files SEC form 8-K, Other Events - EDGAR Online  - Fri, Nov 20
•Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome - Business Wire  - Thu, Nov 19
•Music to Health-Care Investors' Ears - Motley Fool  - Tue, Nov 17
» More Headlines for XNPT...

ANALYST

 
EPS Est (next year) (Dec-09) :-2.41
EPS Est (in 2 years) (Dec-10) :-2.29
Avg Rec (current)*:2.1
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs.

» Full Company Profile